Arrhythmias & electrophysiology

Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes

JACC Cardiovasc IntervPublished Multicentre registry study

Authors' conclusion

About one-third of DRT events had an unfavorable evolution (either persisting or recurring), with a larger initial thrombus size (particularly >7 mm) portending an increased risk. Unfavorable evolution of DRT was associated with a 2-fold higher risk of thromboembolic events compared with resolved DRT.

Study context

Population
Left atrial appendage closure (LAAC) recipients with device-related thrombus and subsequent imaging after initial device-related thrombus (DRT) diagnosisof 237 with DRT
Participants
214 recipients
Exposure
Unfavorable evolution vs resolved DRT
  • Unfavorable evolutionn = 75
Outcome
Incidence, predictors and clinical impact of persistent and recurrent DRT
Methodological detailsinternational
  • International

Main finding

As reported in the abstract

Evolution of DRT

DRT resolved

153

71.5%

DRT persisted

61

28.5%

Recurrent DRT among 82 with repeated imaging after resolution

14

17.1%

Unfavorable evolution overall

75

35.0%

Observational data: associations, not effects.

Further findings

OutcomeUnfavorable evolutionResolved DRTEstimateP value
Predictors of persistent DRTLarger DRT size (per 1-mm increase) · independentOR 1.08 (95% CI 1.02–1.15)P = 0.009
Predictor of unfavorable evolution: average thrombus size at initial diagnosisThrombus size (per 1-mm increase) · sole predictorOR 1.09 (95% CI 1.03–1.16)P = 0.003
Thromboembolic events26.7%15.1%HR 2.13 (95% CI 1.15–3.94)P = 0.02

Predictors of persistent DRT

OR (95% CI)P value
FemaleIndependent2.44 (1.12–5.26)P = 0.02

Predictor of unfavorable evolution: average thrombus size at initial diagnosis

OR (95% CI)P value
Size cutoff 7 mmOptimal cutoff2.51 (1.39–4.52)P = 0.002

Original publication

Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes. JACC Cardiovasc Interv. Published 27 November 2023. doi:10.1016/j.jcin.2023.09.017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.